These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 24780460)

  • 1. Glycemic exposure, glycemic control, and metabolic karma in diabetic complications.
    Thomas MC
    Adv Chronic Kidney Dis; 2014 May; 21(3):311-7. PubMed ID: 24780460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic memory: Evolving concepts.
    Misra A; Bloomgarden Z
    J Diabetes; 2018 Mar; 10(3):186-187. PubMed ID: 29091343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic memory and diabetic nephropathy: potential role for epigenetic mechanisms.
    Tonna S; El-Osta A; Cooper ME; Tikellis C
    Nat Rev Nephrol; 2010 Jun; 6(6):332-41. PubMed ID: 20421885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic memory and diabetic nephropathy: Beneficial effects of natural epigenetic modifiers.
    Kushwaha K; Sharma S; Gupta J
    Biochimie; 2020 Mar; 170():140-151. PubMed ID: 31954720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic Mechanisms in Diabetic Kidney Disease.
    Thomas MC
    Curr Diab Rep; 2016 Mar; 16(3):31. PubMed ID: 26908156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetic retinopathy, metabolic memory and epigenetic modifications.
    Kowluru RA
    Vision Res; 2017 Oct; 139():30-38. PubMed ID: 28700951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycemic control in diabetic CKD patients: where do we stand?
    Kovesdy CP; Sharma K; Kalantar-Zadeh K
    Am J Kidney Dis; 2008 Oct; 52(4):766-77. PubMed ID: 18572289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycemic memory associated epigenetic changes.
    Siebel AL; Fernandez AZ; El-Osta A
    Biochem Pharmacol; 2010 Dec; 80(12):1853-9. PubMed ID: 20599797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on glycemic control for the treatment of diabetic kidney disease.
    Nadkarni GN; Yacoub R; Coca SG
    Curr Diab Rep; 2015 Jul; 15(7):42. PubMed ID: 25971619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetics: mechanisms and implications for diabetic complications.
    Cooper ME; El-Osta A
    Circ Res; 2010 Dec; 107(12):1403-13. PubMed ID: 21148447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can improved glycemic control slow renal function decline at all stages of diabetic nephropathy?
    Goel G; Perkins BA
    Semin Nephrol; 2012 Sep; 32(5):423-31. PubMed ID: 23062982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of hyperglycemia and diabetic nephropathy: effect of reinstitution of good metabolic control on oxidative stress in the kidney of diabetic rats.
    Kowluru RA; Abbas SN; Odenbach S
    J Diabetes Complications; 2004; 18(5):282-8. PubMed ID: 15337502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycemic memories and the epigenetic component of diabetic nephropathy.
    Keating ST; El-Osta A
    Curr Diab Rep; 2013 Aug; 13(4):574-81. PubMed ID: 23639991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diabetic nephropathy: oral anti-diabetic agents or insulin?].
    Gigante E
    G Ital Nefrol; 2006; 23 Suppl 34():S64-7. PubMed ID: 16633998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term intensive glycemic control improves vibratory sensation in type 2 diabetes.
    Fujita Y; Fukushima M; Suzuki H; Taniguchi A; Nakai Y; Kuroe A; Yasuda K; Hosokawa M; Yamada Y; Inagaki N; Seino Y
    Diabetes Res Clin Pract; 2008 Apr; 80(1):e16-9. PubMed ID: 18262304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of epigenetic mechanisms in the development of chronic complications of diabetes.
    Wegner M; Neddermann D; Piorunska-Stolzmann M; Jagodzinski PP
    Diabetes Res Clin Pract; 2014 Aug; 105(2):164-75. PubMed ID: 24814876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetics and epigenomics in diabetic kidney disease and metabolic memory.
    Kato M; Natarajan R
    Nat Rev Nephrol; 2019 Jun; 15(6):327-345. PubMed ID: 30894700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of hyperglycemia in patients with chronic kidney disease.
    Aires Neto P; Gomes HV; Campos M
    J Nephrol; 2013; 26(4):629-35. PubMed ID: 23807643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association between intensive glycemic control and vascular complications in type 2 diabetes mellitus: a meta-analysis.
    Ma J; Yang W; Fang N; Zhu W; Wei M
    Nutr Metab Cardiovasc Dis; 2009 Nov; 19(9):596-603. PubMed ID: 19819121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic phenomena linked to diabetic complications.
    Pirola L; Balcerczyk A; Okabe J; El-Osta A
    Nat Rev Endocrinol; 2010 Dec; 6(12):665-75. PubMed ID: 21045787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.